Skip to main content
. 2018 Jan 3;9(11):9825–9837. doi: 10.18632/oncotarget.23934

Figure 1. The frequency of IL-17-expressing T cells increases in the peripheral blood of patients with HNC.

Figure 1

Isolated PBMCs from healthy donors and patients with HNC and the percentage of IL-17-expressing cells, Th17 and Tc17, was evaluated by flow cytometric analysis. (A) Representative plots for identification of IL-17 producing cells in PBMC, CD4+ or CD8+ populations. (B–C) Analysis of the frequency of IL-17 producing cells from the PBMCs of healthy donors in comparison to HNC patients with tumors at different stages. Each dot represents an individual sample.